Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis
NCT ID: NCT04070027
Last Updated: 2025-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
109 participants
INTERVENTIONAL
2019-09-02
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to investigate whether total hip arthroplasty followed by standard care is superior to progressive resistance training for improving hip function and pain in patients with end-stage hip osteoarthritis.
The hypothesis is that patients treated with total hip arthroplasty will improve more than patients treated with progressive resistance training.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Resistance Training in Patients Scheduled for Total Hip Arthroplasty
NCT01164111
Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement
NCT05657054
Prehabilitation in Older People Undergoing Total Hip Replacement
NCT07048080
Early Rehabilitation After Total Hip Replacement
NCT01214954
Is Periacetabular Osteotomy Superior to Progressive Resistance Training?
NCT03941171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Exercise has been shown to improve physical function and reduce pain in people with hip OA, and is recommended initially as a treatment in international clinical guidelines. Furthermore, a recent randomised controlled trial (RCT) showed clinically relevant improvements in ADL and muscle function after 10-weeks of supervised explosive-type progressive resistance training (PRT) in patients with end-stage hip OA scheduled for THA compared to standard preoperative care.
To date, no RCTs have investigated the effect of THA followed by standard postoperative care compared to supervised explosive-type PRT in patients with end-stage hip OA. Therefore, this highlights the need for a high-quality trial as it is unknown whether non-surgical treatment may be used as an alternate to surgery.
The aim of this randomised controlled trial is to investigate whether THA followed by standard care is superior to a 12-week supervised explosive-type PRT programme for improving patient-reported hip function and pain 6 months after initiating the intervention, measured using the Oxford Hip Score (OHS), in patients with end-stage hip OA eligible for THA. Exploratory outcome time-points will be assessed at 3, 12, 24 and 60 months after initiating the intervention.
The hypothesis is that THA followed by standard care is superior to a 12-week supervised explosive-type PRT programme for improving patient-reported hip function and pain 6 months after initiating the intervention, measured using the OHS, in patients with end-stage hip OA eligible for THA.
Observational cohort:
Patients fulfilling the eligibility criteria but declining to participate in the RCT will be asked to participate in a prospective observational cohort study using the same primary end-point (6 months), exploratory time-points (3, 12, 24 and 60 months), and patient-reported outcomes, but following usual clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total Hip Arthroplasty
A standard fast-track multimodal surgical program comprising patient information, optimised pain management, and early mobilisation. Total hip arthroplasty (THA) will be performed by experienced orthopaedic surgeons in accordance with the standard posterior surgical approach. Patients will receive standard postoperative rehabilitation consisting of either a standard leaflet with a hospital-specific home-based exercise program aimed at increasing hip muscle strength and range of motion or, if considered necessary, a referral to supervised hip-specific exercise therapy delivered at private physiotherapist clinics or municipal rehabilitation. Furthermore, postsurgical procedures will follow hospital-specific procedures ranging from no postsurgical control to postsurgical assessment of the hip and rehabilitation at the physiotherapy department (after six-weeks).
Total Hip Arthroplasty
Total hip arthroplasty following standard procedures.
Progressive Resistance Training
A 12-week supervised explosive-type progressive resistance training (PRT) program with two training sessions a week. All training sessions will be conducted in municipal rehabilitation centres with one-to-one supervision and ≥48 hours of rest in between sessions. The standardised PRT program will consist of warm-up on a stationary bicycle (10 min) followed by four lower extremity exercises (50 min). Exercises will be performed unilaterally with as full range of motion as possible in sets of three separated by 60 sec of rest in the following order: leg press, hip extension, hip flexion, and hip abduction. Patients will be instructed to complete the concentric phase of each repetition "as fast as possible", maintain full extension for 1 sec, and perform the eccentric phase in 2-3 sec. Hip-related pain up to 5 rated on a Numerical Rating Scale (0-10) is considered acceptable during exercises. After the 12-weeks, patients will be offered three-months of optional unsupervised PRT.
Progressive Resistance Training
Progressive resistance training based on available evidence on patients with hip osteoarthritis and designed in accordance with the "American College of Sports Medicine" (ACSM) recommendations for progression models in resistance training aiming at inducing muscle hypertrophy and increasing muscle strength and power.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total Hip Arthroplasty
Total hip arthroplasty following standard procedures.
Progressive Resistance Training
Progressive resistance training based on available evidence on patients with hip osteoarthritis and designed in accordance with the "American College of Sports Medicine" (ACSM) recommendations for progression models in resistance training aiming at inducing muscle hypertrophy and increasing muscle strength and power.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical history and symptoms consistent with primary hip osteoarthritis (including hip osteoarthritis due to mild hip dysplasia that may be treated with standard components) and radiographic verified hip osteoarthritis defined as joint space narrowing \<2 mm
3. Considered eligible for total hip arthroplasty by an orthopaedic surgeon (i.e. duration of symptoms \>3 months, hip related pain, functional impairment or decreased range of motion (ROM), and attempted treatment with analgesics)
Exclusion Criteria
2. Body Mass Index \>35 kg/m2
3. Lower extremity fractures within one-year prior to inclusion
4. Planned other lower extremity surgery within six months
5. Cancer diagnosis and receiving chemo-, immuno- or radiotherapy
6. Neurological diseases (e.g. previous stroke, multiple sclerosis, Parkinson's, Alzheimer's).
7. Other reasons for exclusion (i.e. inadequacy in written and spoken Danish, mentally unable to participate, physically unable to comply with the PRT protocol due to comorbidity (e.g. severe heart disease, previous major lower extremity surgery within six-months) etc.).
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Naestved Hospital
OTHER
Aarhus University Hospital
OTHER
The Danish Rheumatism Association
OTHER
Region of Southern Denmark
OTHER
Association of Danish Physiotherapists
OTHER
The Research Council at Naestved-Slagelse-Ringsted Hospitals
UNKNOWN
Vejle Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Frydendal, PT, MSc
Role: PRINCIPAL_INVESTIGATOR
Vejle Hospital and University of Southern Denmark
Søren Overgaard, Prof., MD
Role: STUDY_DIRECTOR
Odense University Hospital and University of Southern Denmark
Inger Mechlenburg, Prof., DMSc
Role: STUDY_CHAIR
Aarhus University Hospital and Aarhus University
Kim Gordon Ingwersen, PT, PhD
Role: STUDY_CHAIR
Vejle Hospital and University of Southern Denmark
Lone Ramer Mikkelsen, PT, PhD
Role: STUDY_CHAIR
Silkeborg Regional Hospital
Robin Christensen, Prof., PhD
Role: STUDY_CHAIR
The Parker Institute and Odense University Hospital
Claus Varnum, PhD, MD
Role: STUDY_CHAIR
Vejle Hospital
Henrik Morville Schrøder, PhD, MD
Role: STUDY_CHAIR
Naestved Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Orthopaedic Surgery, Aarhus University Hospital (AUH)
Aarhus, , Denmark
Department of Orthopaedic Surgery, Naestved Hospital
Næstved, , Denmark
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital (OUH)
Odense, , Denmark
Depatment of Orthopaedic Surgery, Vejle Hospital
Vejle, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bryld ES, Christiansen L, Ingwersen KG, Overgaard S, Mikkelsen LR, Mechlenburg I, Frydendal T. Training load and pain response during progressive resistance training in patients with hip osteoarthritis in the PROHIP trial. Osteoarthr Cartil Open. 2025 Oct 4;7(4):100690. doi: 10.1016/j.ocarto.2025.100690. eCollection 2025 Dec.
Frydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Varnum C, Graversen AE, Kjaersgaard-Andersen P, Revald PH, Hofbauer C, Bieder MJ, Qassim H, Munir MS, Jakobsen SS, Nielsen SM, Ingwersen KG, Overgaard S. Total Hip Replacement or Resistance Training for Severe Hip Osteoarthritis. N Engl J Med. 2024 Oct 31;391(17):1610-1620. doi: 10.1056/NEJMoa2400141.
Frydendal T, Thomsen KS, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG, Myburgh C. Patient and public involvement to inform the protocol of a clinical trial comparing total hip arthroplasty with exercise: an exploratory qualitative case study. BMJ Open. 2023 Apr 24;13(4):e070866. doi: 10.1136/bmjopen-2022-070866.
Frydendal T, Christensen R, Mechlenburg I, Mikkelsen LR, Overgaard S, Ingwersen KG. Total hip arthroplasty versus progressive resistance training in patients with severe hip osteoarthritis: protocol for a multicentre, parallel-group, randomised controlled superiority trial. BMJ Open. 2021 Oct 22;11(10):e051392. doi: 10.1136/bmjopen-2021-051392.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan: Statistical Analysis Plan: RCT
Document Type: Statistical Analysis Plan: Statistical Analysis Plan: Generalizability
Document Type: Statistical Analysis Plan: Statistical Analysis Plan: Physical Activity
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R153-A4771
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
R161-A5280
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
R166-A5553
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
R176-A6231
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
18/41994
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
17/33622
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
S-20180158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.